Perkenalan
Halaman ini memberikan analisis komprehensif tentang riwayat insider trading yang diketahui di Mark G Foletta. Insider adalah pejabat, direktur, atau investor penting dalam suatu perusahaan. Adalah ilegal bagi insider untuk melakukan perdagangan di perusahaan mereka berdasarkan informasi spesifik dan non-publik. Hal ini tidak berarti bahwa mereka dilarang melakukan perdagangan apa pun di perusahaan mereka sendiri. Namun, mereka harus melaporkan semua perdagangan ke SEC melalui Formulir 4. Meskipun ada pembatasan ini, penelitian akademis menunjukkan bahwa insider – secara umum – cenderung mengungguli pasar di perusahaan mereka sendiri.
Profitabilitas Perdagangan Rata-rata
Profitabilitas perdagangan rata-rata adalah pengembalian rata-rata dari seluruh pembelian pasar terbuka yang dilakukan oleh insider dalam 3 tahun terakhir. Untuk menghitungnya, kami memeriksa setiap pembelian pasar terbuka dan tidak terencana yang dilakukan oleh insider, tidak termasuk semua perdagangan yang ditandai sebagai bagian dari rencana perdagangan 10b5-1. Kami kemudian menghitung kinerja rata-rata perdagangan tersebut selama 3, 6, dan 12 bulan, merata-ratakan setiap durasi tersebut untuk menghasilkan metrik kinerja akhir untuk setiap perdagangan. Terakhir, kami menghitung rata-rata semua metrik kinerja untuk menghitung metrik kinerja bagi insider. Daftar ini hanya mencakup insider yang telah melakukan setidaknya tiga perdagangan dalam 2 tahun terakhir.
Jika profitabilitas perdagangan insider ini adalah "T/A", maka insider tersebut belum melakukan pembelian di pasar terbuka dalam 3 tahun terakhir, atau perdagangan yang mereka lakukan terlalu baru untuk menghitung metrik kinerja yang dapat diandalkan.
Frekuensi Pembaruan: Harian
Perusahaan dengan Posisi Insider yang Dilaporkan
Pengajuan SEC menunjukkan Mark G Foletta telah melaporkan kepemilikan atau perdagangan di perusahaan berikut:
| Keamanan | Judul | Kepemilikan Terbaru yang Dilaporkan |
|---|---|---|
| US:DXCM / DexCom, Inc. | Director | 6.331 |
| US:AMN / AMN Healthcare Services, Inc. | Director | 21.598 |
| US:ENTA / Enanta Pharmaceuticals, Inc. | Director | 7.500 |
| US:TOCA / Tocagen Inc. | EVP & Chief Financial Officer | 30.000 |
| US:RGLS / Regulus Therapeutics Inc. | Director | 81.910 |
| US:BIOC / Biocept Inc | Interim CFO | 50.000 |
| Director | 0 | |
| US:AMLN / Amylin Pharmaceuticals Inc | SVP, Chief Financial Officer | 0 |
Bagaimana Menafsirkan Grafik
Bagan berikut menunjukkan kinerja saham sekuritas setelah setiap perdagangan pasar terbuka dan tidak terencana yang dilakukan oleh Mark G Foletta. Perdagangan yang tidak direncanakan adalah perdagangan yang tidak dilakukan sebagai bagian dari rencana perdagangan 10b5-1. Kinerja saham dipetakan sebagai persentase perubahan kumulatif harga saham. Misalnya, jika perdagangan insider dilakukan pada tanggal 1 Januari 2019, grafik akan menunjukkan persentase perubahan harian sekuritas hingga hari ini. Jika harga saham naik dari $10 menjadi $15 selama waktu ini, persentase perubahan harga saham kumulatif akan menjadi 50%. Perubahan harga dari $10 menjadi $20 adalah 100%, dan perubahan harga dari $10 menjadi $5 adalah -50%.
Pada akhirnya, kami mencoba untuk menentukan seberapa dekat korelasi perdagangan insider dengan keuntungan berlebih (positif atau negatif) pada harga saham untuk melihat apakah insider mengatur waktu perdagangannya untuk mendapatkan keuntungan dari informasi insider. Pertimbangkan situasi di mana insider melakukan hal ini. Dalam situasi ini, kita mengharapkan (a) keuntungan positif setelah pembelian, atau (b) keuntungan negatif setelah penjualan. Dalam kasus (a), grafik PEMBELIAN akan menunjukkan serangkaian kurva yang miring ke atas, yang menunjukkan keuntungan positif setelah setiap transaksi pembelian. Dalam kasus (b), grafik PENJUALAN akan menunjukkan serangkaian kurva yang miring ke bawah, yang menunjukkan keuntungan negatif setelah setiap transaksi penjualan.
Namun, hal ini saja tidak cukup untuk menarik kesimpulan. Jika, misalnya, harga saham perusahaan berada dalam kenaikan non-siklus selama bertahun-tahun, maka kita perkirakan semua lahan pasca pembelian akan miring ke atas. Demikian pula, penurunan non-siklus selama bertahun-tahun akan mengakibatkan penurunan pasca-perdagangan. Tak satu pun dari grafik ini menunjukkan aktivitas insider trading.
Indikator terkuat adalah situasi di mana harga saham sangat bersiklus, dan terdapat sinyal positif pada grafik PEMBELIAN dan plot negatif pada grafik PENJUALAN. Situasi ini akan sangat memberi isyarat kepada insider yang mengatur waktu perdagangan demi keuntungan finansial mereka.
Pembelian Insider AMN / AMN Healthcare Services, Inc. - Analisis Keuntungan Jangka Pendek
Di bagian ini, kami menganalisis profitabilitas setiap pembelian insider di pasar terbuka yang tidak direncanakan dan dilakukan pada AMN / AMN Healthcare Services, Inc.. Analisis ini membantu untuk memahami apakah insider secara konsisten menghasilkan keuntungan yang tidak normal, dan layak untuk diikuti. Analisis ini dilakukan selama satu tahun setelah setiap perdagangan dan hasilnya bersifat teoretis .
Tabel berikut ini menunjukkan pembelian pasar terbuka terkini yang bukan merupakan bagian dari rencana perdagangan otomatis.
| Tanggal Perdagangan | Kode | Insider | Dilaporkan Saham |
Dilaporkan Harga |
Disesuaikan Saham |
Disesuaikan Harga |
Dasar Biaya | Hari ke Maksimal |
Harga di Maksimal |
Maksimal Keuntungan ($) |
Pengembalian Maksimal (%) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-02-29 | AMN | FOLETTA MARK G | 500 | 56,9000 | 500 | 56,9000 | 28.450 | 152 | 68.0500 | 5.575 | 19,60 |
Harga yang Disesuaikan adalah harga yang disesuaikan secara terpisah. Saham yang Disesuaikan adalah saham yang disesuaikan dengan pembagiannya.
Penjualan Insider AMN / AMN Healthcare Services, Inc. - Analisis Kerugian Jangka Pendek
Di bagian ini, kami menganalisis penghindaran kerugian jangka pendek dari setiap penjualan insider di pasar terbuka yang tidak direncanakan dan dilakukan di AMN / AMN Healthcare Services, Inc.. Pola penghindaran kerugian yang konsisten mungkin menunjukkan bahwa transaksi penjualan pada masa depan dapat memprediksi penurunan harga. Analisis ini dilakukan selama satu tahun setelah setiap perdagangan dan hasilnya bersifat teoretis .
Tabel berikut ini menunjukkan penjualan pasar terbuka terkini yang bukan merupakan bagian dari rencana perdagangan otomatis.
Harga yang Disesuaikan adalah harga yang disesuaikan secara terpisah. Saham yang Disesuaikan adalah saham yang disesuaikan dengan pembagiannya.
Pembelian Insider ENTA / Enanta Pharmaceuticals, Inc. - Analisis Keuntungan Jangka Pendek
Di bagian ini, kami menganalisis profitabilitas setiap pembelian insider di pasar terbuka yang tidak direncanakan dan dilakukan pada AMN / AMN Healthcare Services, Inc.. Analisis ini membantu untuk memahami apakah insider secara konsisten menghasilkan keuntungan yang tidak normal, dan layak untuk diikuti. Analisis ini dilakukan selama satu tahun setelah setiap perdagangan dan hasilnya bersifat teoretis .
Tabel berikut ini menunjukkan pembelian pasar terbuka terkini yang bukan merupakan bagian dari rencana perdagangan otomatis.
| Tanggal Perdagangan | Kode | Insider | Dilaporkan Saham |
Dilaporkan Harga |
Disesuaikan Saham |
Disesuaikan Harga |
Dasar Biaya | Hari ke Maksimal |
Harga di Maksimal |
Maksimal Keuntungan ($) |
Pengembalian Maksimal (%) |
|---|---|---|---|---|---|---|---|
| Tidak ada perdagangan pasar terbuka yang tidak direncanakan untuk kombinasi insider dan keamanan ini |
Harga yang Disesuaikan adalah harga yang disesuaikan secara terpisah. Saham yang Disesuaikan adalah saham yang disesuaikan dengan pembagiannya.
Penjualan Insider ENTA / Enanta Pharmaceuticals, Inc. - Analisis Kerugian Jangka Pendek
Di bagian ini, kami menganalisis penghindaran kerugian jangka pendek dari setiap penjualan insider di pasar terbuka yang tidak direncanakan dan dilakukan di AMN / AMN Healthcare Services, Inc.. Pola penghindaran kerugian yang konsisten mungkin menunjukkan bahwa transaksi penjualan pada masa depan dapat memprediksi penurunan harga. Analisis ini dilakukan selama satu tahun setelah setiap perdagangan dan hasilnya bersifat teoretis .
Tabel berikut ini menunjukkan penjualan pasar terbuka terkini yang bukan merupakan bagian dari rencana perdagangan otomatis.
| Tanggal Perdagangan | Kode | Insider | Dilaporkan Saham |
Dilaporkan Harga |
Disesuaikan Saham |
Disesuaikan Harga |
Dasar Biaya | Hari ke Minimal |
Harga di Minimal |
Kerugian Maksimal Dihindari ($) |
Kerugian Maksimal Dihindari (%) |
|---|---|---|---|---|---|---|---|
| Tidak ada perdagangan pasar terbuka yang tidak direncanakan untuk kombinasi insider dan keamanan ini |
Harga yang Disesuaikan adalah harga yang disesuaikan secara terpisah. Saham yang Disesuaikan adalah saham yang disesuaikan dengan pembagiannya.
Pembelian Insider FBRX / Forte Biosciences, Inc. - Analisis Keuntungan Jangka Pendek
Di bagian ini, kami menganalisis profitabilitas setiap pembelian insider di pasar terbuka yang tidak direncanakan dan dilakukan pada AMN / AMN Healthcare Services, Inc.. Analisis ini membantu untuk memahami apakah insider secara konsisten menghasilkan keuntungan yang tidak normal, dan layak untuk diikuti. Analisis ini dilakukan selama satu tahun setelah setiap perdagangan dan hasilnya bersifat teoretis .
Tabel berikut ini menunjukkan pembelian pasar terbuka terkini yang bukan merupakan bagian dari rencana perdagangan otomatis.
Harga yang Disesuaikan adalah harga yang disesuaikan secara terpisah. Saham yang Disesuaikan adalah saham yang disesuaikan dengan pembagiannya.
Penjualan Insider FBRX / Forte Biosciences, Inc. - Analisis Kerugian Jangka Pendek
Di bagian ini, kami menganalisis penghindaran kerugian jangka pendek dari setiap penjualan insider di pasar terbuka yang tidak direncanakan dan dilakukan di AMN / AMN Healthcare Services, Inc.. Pola penghindaran kerugian yang konsisten mungkin menunjukkan bahwa transaksi penjualan pada masa depan dapat memprediksi penurunan harga. Analisis ini dilakukan selama satu tahun setelah setiap perdagangan dan hasilnya bersifat teoretis .
Tabel berikut ini menunjukkan penjualan pasar terbuka terkini yang bukan merupakan bagian dari rencana perdagangan otomatis.
| Tanggal Perdagangan | Kode | Insider | Dilaporkan Saham |
Dilaporkan Harga |
Disesuaikan Saham |
Disesuaikan Harga |
Dasar Biaya | Hari ke Minimal |
Harga di Minimal |
Kerugian Maksimal Dihindari ($) |
Kerugian Maksimal Dihindari (%) |
|---|---|---|---|---|---|---|---|
| Tidak ada perdagangan pasar terbuka yang tidak direncanakan untuk kombinasi insider dan keamanan ini |
Harga yang Disesuaikan adalah harga yang disesuaikan secara terpisah. Saham yang Disesuaikan adalah saham yang disesuaikan dengan pembagiannya.
Riwayat Insider Trading
Tabel ini menunjukkan daftar lengkap perdagangan insider yang dilakukan oleh Mark G Foletta sebagaimana diungkapkan kepada Securities Exchange Commission (SEC).
| Tanggal Berkas | Tanggal Trans | Formulir | Kode | Keamanan | Kode | Saham | Sisa Saham | Persen Mengubah |
Saham Harga |
Trans Nilai |
Tersisa Nilai |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-01 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
A - Award | 6.331 | 6.331 | |||||
| 2026-05-11 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
G - Gift | 5.731 | 56.852 | 11,21 | ||||
| 2026-05-11 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
G - Gift | -5.731 | 0 | -100,00 | ||||
| 2026-05-04 |
|
4 | AMN |
AMN HEALTHCARE SERVICES INC
Common Stock |
M - Exercise | 8.325 | 21.598 | 62,72 | ||||
| 2025-08-18 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | -195 | 51.121 | -0,38 | 81,54 | -15.900 | 4.168.406 | |
| 2025-08-18 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | -2.555 | 51.316 | -4,74 | 81,02 | -207.003 | 4.157.550 |
| 2025-07-17 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | -8 | 53.871 | -0,01 | 86,03 | -688 | 4.634.522 | |
| 2025-07-17 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | -2.742 | 53.879 | -4,84 | 85,17 | -233.528 | 4.588.724 |
| 2025-06-18 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | -2.750 | 56.621 | -4,63 | 83,13 | -228.605 | 4.706.847 |
| 2025-05-12 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
A - Award | 5.731 | 5.731 | |||||
| 2025-05-12 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
G - Gift | 2.973 | 59.371 | 5,27 | ||||
| 2025-05-12 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
G - Gift | -2.973 | 0 | -100,00 | ||||
| 2025-04-21 |
|
4 | AMN |
AMN HEALTHCARE SERVICES INC
Common Stock |
M - Exercise | 3.019 | 13.273 | 29,44 | ||||
| 2024-06-20 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | -299 | 56.398 | -0,53 | 117,25 | -35.056 | 6.612.412 |
| 2024-06-20 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | -3.007 | 56.697 | -5,04 | 116,75 | -351.065 | 6.619.335 |
| 2024-06-20 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | -475 | 59.704 | -0,79 | 117,77 | -55.942 | 7.031.442 |
| 2024-06-20 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | -2.212 | 60.179 | -3,55 | 117,16 | -259.159 | 7.050.614 |
| 2024-06-20 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | -7 | 62.391 | -0,01 | 115,18 | -806 | 7.186.195 |
| 2024-05-24 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
A - Award | 2.973 | 2.973 | |||||
| 2024-05-21 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
G - Gift | 3.306 | 62.398 | 5,59 | ||||
| 2024-05-21 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
G - Gift | -3.306 | 0 | -100,00 | ||||
| 2024-04-23 |
|
4 | AMN |
AMN HEALTHCARE SERVICES INC
Common Stock |
M - Exercise | 1.681 | 10.254 | 19,61 | ||||
| 2024-03-01 |
|
4 | AMN |
AMN HEALTHCARE SERVICES INC
Common Stock |
P - Purchase | 500 | 8.573 | 6,19 | 56,90 | 28.450 | 487.804 | |
| 2023-05-22 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
G - Gift | 4.488 | 59.092 | 8,22 | ||||
| 2023-05-22 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
G - Gift | -4.488 | 3.306 | -57,58 | ||||
| 2023-05-22 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
A - Award | 3.306 | 7.794 | 73,66 | 0,00 | 3 | 8 | |
| 2023-04-25 |
|
4 | AMN |
AMN HEALTHCARE SERVICES INC
Common Stock |
S - Sale | X | -1.458 | 8.073 | -15,30 | 88,78 | -129.441 | 716.721 |
| 2023-04-25 |
|
4 | AMN |
AMN HEALTHCARE SERVICES INC
Common Stock |
M - Exercise | 1.458 | 9.531 | 18,06 | ||||
| 2023-04-13 |
|
4 | AMN |
AMN HEALTHCARE SERVICES INC
Common Stock |
S - Sale | X | -1.053 | 8.073 | -11,54 | 84,63 | -89.115 | 683.218 |
| 2023-04-13 |
|
4 | AMN |
AMN HEALTHCARE SERVICES INC
Common Stock |
S - Sale | X | -4.989 | 9.126 | -35,35 | 84,29 | -420.523 | 769.231 |
| 2022-12-16 |
|
4 | AMN |
AMN HEALTHCARE SERVICES INC
Common Stock |
G - Gift | -300 | 14.115 | -2,08 | ||||
| 2022-05-23 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
A - Award | 1.122 | 1.122 | 0,00 | 1 | 1 | ||
| 2022-05-23 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
J - Other | 1.054 | 13.651 | 8,37 | ||||
| 2022-05-23 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
J - Other | -1.054 | 0 | -100,00 | ||||
| 2022-04-22 |
|
4 | AMN |
AMN HEALTHCARE SERVICES INC
Restricted Stock Units |
A - Award | 1.458 | 1.458 | |||||
| 2022-04-22 |
|
4 | AMN |
AMN HEALTHCARE SERVICES INC
Restricted Stock Units |
M - Exercise | -2.139 | 0 | -100,00 | ||||
| 2022-04-22 |
|
4 | AMN |
AMN HEALTHCARE SERVICES INC
Common Stock |
M - Exercise | 2.139 | 14.415 | 17,42 | ||||
| 2022-03-07 |
|
4 | ENTA |
ENANTA PHARMACEUTICALS INC
Stock Option (right to buy) |
A - Award | 7.500 | 7.500 | |||||
| 2021-12-02 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | -41 | 12.597 | -0,32 | 569,54 | -23.351 | 7.174.475 |
| 2021-12-02 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | -2 | 12.638 | -0,02 | 567,35 | -1.135 | 7.170.201 |
| 2021-12-02 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | -87 | 12.640 | -0,68 | 565,51 | -49.200 | 7.148.082 |
| 2021-12-02 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | -65 | 12.727 | -0,51 | 564,24 | -36.675 | 7.181.054 |
| 2021-12-02 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | -116 | 12.792 | -0,90 | 562,79 | -65.283 | 7.199.188 |
| 2021-12-02 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | -78 | 12.908 | -0,60 | 561,85 | -43.824 | 7.252.369 |
| 2021-12-02 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | -70 | 12.986 | -0,54 | 558,78 | -39.115 | 7.256.325 |
| 2021-12-02 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | -41 | 13.056 | -0,31 | 556,89 | -22.832 | 7.270.756 |
| 2021-11-02 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | -40 | 13.097 | -0,30 | 634,01 | -25.360 | 8.303.629 |
| 2021-11-02 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | -40 | 13.137 | -0,30 | 631,26 | -25.250 | 8.292.863 |
| 2021-11-02 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | -42 | 13.177 | -0,32 | 629,33 | -26.432 | 8.292.681 |
| 2021-11-02 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | -76 | 13.219 | -0,57 | 628,41 | -47.759 | 8.306.917 |
| 2021-11-02 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | -56 | 13.295 | -0,42 | 627,79 | -35.156 | 8.346.529 |
| 2021-11-02 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | -7 | 13.351 | -0,05 | 626,04 | -4.382 | 8.358.327 |
| 2021-11-02 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | -124 | 13.358 | -0,92 | 625,32 | -77.540 | 8.353.007 |
| 2021-11-02 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | -43 | 13.482 | -0,32 | 624,10 | -26.836 | 8.414.076 |
| 2021-11-02 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | -13 | 13.525 | -0,10 | 622,62 | -8.094 | 8.421.003 |
| 2021-11-02 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | -14 | 13.538 | -0,10 | 619,32 | -8.670 | 8.384.354 |
| 2021-11-02 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | -45 | 13.552 | -0,33 | 615,13 | -27.681 | 8.336.242 |
| 2021-10-05 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | -1 | 13.597 | -0,01 | 551,58 | -552 | 7.499.833 |
| 2021-10-05 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | -51 | 13.598 | -0,37 | 547,06 | -27.900 | 7.438.906 |
| 2021-10-05 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | -181 | 13.649 | -1,31 | 544,39 | -98.535 | 7.430.420 |
| 2021-10-05 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | -126 | 13.830 | -0,90 | 543,15 | -68.437 | 7.511.733 |
| 2021-10-05 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | -88 | 13.956 | -0,63 | 540,93 | -47.602 | 7.549.219 |
| 2021-10-05 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | -6 | 14.044 | -0,04 | 539,10 | -3.235 | 7.571.120 |
| 2021-10-05 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | -47 | 14.050 | -0,33 | 538,02 | -25.287 | 7.559.181 |
| 2021-06-15 |
|
4 | AMN |
AMN HEALTHCARE SERVICES INC
Common Stock |
S - Sale | -2.500 | 12.276 | -16,92 | 95,02 | -237.540 | 1.166.416 | |
| 2021-05-25 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
A - Award | 1.054 | 1.054 | 0,00 | 1 | 1 | ||
| 2021-05-25 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
J - Other | 895 | 14.097 | 6,78 | ||||
| 2021-05-25 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
J - Other | -895 | 0 | -100,00 | ||||
| 2021-04-23 |
|
4 | AMN |
AMN HEALTHCARE SERVICES INC
Restricted Stock Units |
A - Award | 2.139 | 2.139 | |||||
| 2021-04-23 |
|
4 | AMN |
AMN HEALTHCARE SERVICES INC
Restricted Stock Units |
M - Exercise | -2.826 | 0 | -100,00 | ||||
| 2021-04-23 |
|
4 | AMN |
AMN HEALTHCARE SERVICES INC
Common Stock |
M - Exercise | 2.826 | 14.776 | 23,65 | ||||
| 2021-03-04 |
|
4 | ENTA |
ENANTA PHARMACEUTICALS INC
Stock Option (right to buy) |
A - Award | 7.500 | 7.500 | |||||
| 2020-11-18 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | -301 | 13.202 | -2,23 | 342,93 | -103.222 | 4.527.349 |
| 2020-11-18 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | -428 | 13.503 | -3,07 | 341,79 | -146.284 | 4.615.136 |
| 2020-11-18 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | -117 | 13.931 | -0,83 | 340,23 | -39.807 | 4.739.798 |
| 2020-11-18 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | -139 | 14.048 | -0,98 | 337,78 | -46.951 | 4.745.133 |
| 2020-11-18 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | -15 | 14.187 | -0,11 | 336,98 | -5.055 | 4.780.745 |
| 2020-10-19 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | -208 | 14.202 | -1,44 | 398,25 | -82.835 | 5.655.907 |
| 2020-10-19 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | -375 | 14.410 | -2,54 | 397,41 | -149.030 | 5.726.730 |
| 2020-10-19 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | -255 | 14.785 | -1,70 | 396,51 | -101.109 | 5.862.349 |
| 2020-10-19 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | -120 | 15.040 | -0,79 | 395,02 | -47.402 | 5.941.101 |
| 2020-10-19 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | -42 | 15.160 | -0,28 | 391,48 | -16.442 | 5.934.902 |
| 2020-09-16 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | -114 | 15.202 | -0,74 | 397,75 | -45.344 | 6.046.623 |
| 2020-09-16 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | -121 | 15.316 | -0,78 | 396,17 | -47.936 | 6.067.692 |
| 2020-09-16 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | -222 | 15.437 | -1,42 | 395,28 | -87.753 | 6.101.970 |
| 2020-09-16 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | -231 | 15.659 | -1,45 | 393,73 | -90.951 | 6.165.388 |
| 2020-09-16 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | -200 | 15.890 | -1,24 | 391,95 | -78.390 | 6.228.060 |
| 2020-09-16 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | -109 | 16.090 | -0,67 | 390,86 | -42.604 | 6.288.905 |
| 2020-09-16 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | -3 | 16.199 | -0,02 | 386,21 | -1.159 | 6.256.216 |
| 2020-07-01 |
|
4 | ENTA |
ENANTA PHARMACEUTICALS INC
Stock Option (right to buy) |
A - Award | 17.000 | 17.000 | |||||
| 2020-05-27 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
A - Award | 895 | 895 | 0,00 | 1 | 1 | ||
| 2020-05-27 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
J - Other | 3.055 | 16.202 | 23,24 | ||||
| 2020-05-27 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
J - Other | -3.055 | 0 | -100,00 | ||||
| 2020-04-24 |
|
4 | AMN |
AMN HEALTHCARE SERVICES INC
Restricted Stock Units |
A - Award | 2.826 | 2.826 | |||||
| 2020-04-21 |
|
4 | AMN |
AMN HEALTHCARE SERVICES INC
Restricted Stock Units |
M - Exercise | -2.907 | 0 | -100,00 | ||||
| 2020-04-21 |
|
4 | AMN |
AMN HEALTHCARE SERVICES INC
Common Stock |
M - Exercise | 2.907 | 11.950 | 32,15 | ||||
| 2020-03-04 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | -84 | 13.147 | -0,63 | 288,26 | -24.214 | 3.789.754 |
| 2020-03-04 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | -75 | 13.231 | -0,56 | 285,48 | -21.411 | 3.777.196 |
| 2020-03-04 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | -84 | 13.306 | -0,63 | 282,77 | -23.753 | 3.762.538 |
| 2020-03-04 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | -53 | 13.390 | -0,39 | 281,60 | -14.925 | 3.770.691 |
| 2020-03-04 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | -31 | 13.443 | -0,23 | 279,60 | -8.668 | 3.758.649 |
| 2020-03-04 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | -64 | 13.474 | -0,47 | 277,48 | -17.759 | 3.738.784 |
| 2020-03-04 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | -114 | 13.538 | -0,84 | 275,56 | -31.414 | 3.730.546 |
| 2020-03-04 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | -155 | 13.652 | -1,12 | 274,88 | -42.607 | 3.752.708 |
| 2020-03-04 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | -81 | 13.807 | -0,58 | 272,82 | -22.098 | 3.766.826 |
| 2020-03-04 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | -152 | 13.888 | -1,08 | 271,54 | -41.274 | 3.771.138 |
| 2020-03-04 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | -107 | 14.040 | -0,76 | 270,63 | -28.957 | 3.799.592 |
| 2020-02-05 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | -9 | 14.147 | -0,06 | 240,68 | -2.166 | 3.404.853 |
| 2020-02-05 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | -166 | 14.156 | -1,16 | 238,86 | -39.650 | 3.381.251 |
| 2020-02-05 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | -524 | 14.322 | -3,53 | 238,05 | -124.736 | 3.409.305 |
| 2020-02-05 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | -301 | 14.846 | -1,99 | 236,84 | -71.290 | 3.516.196 |
| 2020-01-07 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | -133 | 15.147 | -0,87 | 218,94 | -29.118 | 3.316.216 |
| 2020-01-07 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | -339 | 15.280 | -2,17 | 218,39 | -74.035 | 3.337.050 |
| 2020-01-07 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | -528 | 15.619 | -3,27 | 217,61 | -114.899 | 3.398.882 |
| 2019-12-05 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | -462 | 16.147 | -2,78 | 228,93 | -105.766 | 3.696.562 |
| 2019-12-05 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | -233 | 16.609 | -1,38 | 227,66 | -53.046 | 3.781.266 |
| 2019-12-05 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | -232 | 16.842 | -1,36 | 226,20 | -52.478 | 3.809.664 |
| 2019-12-05 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | -70 | 17.074 | -0,41 | 223,41 | -15.639 | 3.814.502 |
| 2019-12-05 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | -3 | 17.144 | -0,02 | 221,34 | -664 | 3.794.653 |
| 2019-10-04 |
|
4 | TOCA |
Tocagen Inc
Employee Stock Option (right to buy) |
A - Award | 30.000 | 30.000 | |||||
| 2019-06-04 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
A - Award | 3.055 | 3.055 | 0,00 | 3 | 3 | ||
| 2019-06-04 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
J - Other | 4.052 | 17.147 | 30,94 | ||||
| 2019-06-04 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
J - Other | -4.052 | 0 | -100,00 | ||||
| 2019-05-29 |
|
4 | TOCA |
Tocagen Inc
Common Stock |
P - Purchase | 5.000 | 15.042 | 49,79 | 4,30 | 21.475 | 64.605 | |
| 2019-05-17 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | -400 | 13.095 | -2,96 | 122,73 | -49.091 | 1.607.101 |
| 2019-05-17 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | -500 | 13.495 | -3,57 | 121,88 | -60.939 | 1.644.744 |
| 2019-05-17 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | -100 | 13.995 | -0,71 | 118,65 | -11.865 | 1.660.507 |
| 2019-04-19 |
|
4 | AMN |
AMN HEALTHCARE SERVICES INC
Restricted Stock Units |
A - Award | 2.907 | 2.907 | |||||
| 2019-04-19 |
|
4 | AMN |
AMN HEALTHCARE SERVICES INC
Restricted Stock Units |
M - Exercise | -2.153 | 0 | -100,00 | ||||
| 2019-04-19 |
|
4 | AMN |
AMN HEALTHCARE SERVICES INC
Common Stock |
M - Exercise | 2.153 | 9.043 | 31,25 | ||||
| 2019-04-17 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | -599 | 14.095 | -4,08 | 119,36 | -71.497 | 1.682.378 |
| 2019-04-17 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | -301 | 14.694 | -2,01 | 118,88 | -35.784 | 1.746.877 |
| 2019-04-17 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | -100 | 14.995 | -0,66 | 116,96 | -11.696 | 1.753.815 |
| 2019-03-19 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | -100 | 15.095 | -0,66 | 151,97 | -15.197 | 2.293.987 |
| 2019-03-19 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | -700 | 15.195 | -4,40 | 151,00 | -105.698 | 2.294.401 |
| 2019-03-19 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | -200 | 15.895 | -1,24 | 146,92 | -29.384 | 2.335.293 |
| 2019-03-05 |
|
4 | TOCA |
Tocagen Inc
Employee Stock Option (right to buy) |
A - Award | 75.000 | 75.000 | |||||
| 2019-02-20 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | -200 | 16.095 | -1,23 | 149,52 | -29.904 | 2.406.524 |
| 2019-02-20 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | -800 | 16.295 | -4,68 | 148,52 | -118.819 | 2.420.195 |
| 2019-02-15 |
|
5 | DXCM |
DEXCOM INC
Common Stock |
J - Other | 4.952 | 18.095 | 37,68 | ||||
| 2019-02-15 |
|
5 | DXCM |
DEXCOM INC
Common Stock |
J - Other | -4.952 | 4.052 | -55,00 | ||||
| 2018-08-28 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | -1.000 | 17.095 | -5,53 | 137,50 | -137.503 | 2.350.614 | |
| 2018-06-26 |
|
4/A | DXCM |
DEXCOM INC
Common Stock |
A - Award | 4.052 | 4.052 | 0,00 | 4 | 4 | ||
| 2018-06-04 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
A - Award | 4.062 | 9.014 | 82,03 | 0,00 | 4 | 9 | |
| 2018-04-20 |
|
4 | AMN |
AMN HEALTHCARE SERVICES INC
Restricted Stock Units |
M - Exercise | -3.365 | 0 | -100,00 | ||||
| 2018-04-20 |
|
4 | AMN |
AMN HEALTHCARE SERVICES INC
Restricted Stock Units |
A - Award | 2.153 | 0 | -100,00 | ||||
| 2018-04-20 |
|
4 | AMN |
AMN HEALTHCARE SERVICES INC
Common Stock |
M - Exercise | 3.365 | 6.890 | 95,46 | ||||
| 2018-03-02 |
|
4 | TOCA |
Tocagen Inc
Employee Stock Option (right to buy) |
A - Award | 85.000 | 85.000 | |||||
| 2017-12-14 |
|
4 | TOCA |
Tocagen Inc
Common Stock |
J - Other | 2.500 | 7.500 | 50,00 | 8,50 | 21.250 | 63.750 | |
| 2017-12-06 |
|
4 | RGLS |
Regulus Therapeutics Inc.
Common Stock |
A - Award | 71.910 | 81.910 | 719,10 | 0,89 | 64.000 | 72.900 | |
| 2017-11-29 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | -2.500 | 13.143 | -15,98 | 54,95 | -137.386 | 722.264 | |
| 2017-11-28 |
|
4 | AMN |
AMN HEALTHCARE SERVICES INC
Common Stock |
S - Sale | -2.500 | 3.525 | -41,49 | 47,03 | -117.575 | 165.781 | |
| 2017-06-14 |
|
4 | AMN |
AMN HEALTHCARE SERVICES INC
Common Stock |
S - Sale | -1.500 | 6.025 | -19,93 | 36,70 | -55.058 | 221.148 | |
| 2017-06-05 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
A - Award | 4.952 | 20.595 | 31,66 | 0,00 | 5 | 21 | |
| 2017-06-02 |
|
4 | RGLS |
Regulus Therapeutics Inc.
Stock Option (Right to Buy) |
A - Award | 30.000 | 30.000 | |||||
| 2017-05-31 |
|
4 | TOCA |
Tocagen Inc
Employee Stock Option (right to buy) |
A - Award | 85.000 | 85.000 | |||||
| 2017-04-21 |
|
4 | TOCA |
Tocagen Inc
Common Stock |
P - Purchase | 5.000 | 5.000 | 10,00 | 50.000 | 50.000 | ||
| 2017-04-20 |
|
4 | AMN |
AMN HEALTHCARE SERVICES INC
Restricted Stock Units |
M - Exercise | -3.793 | 0 | -100,00 | ||||
| 2017-04-20 |
|
4 | AMN |
AMN HEALTHCARE SERVICES INC
Common Stock |
M - Exercise | 3.793 | 7.525 | 101,63 | ||||
| 2017-04-20 |
|
4 | AMN |
AMN HEALTHCARE SERVICES INC
Restricted Stock Units |
A - Award | 3.365 | 3.365 | |||||
| 2016-12-16 |
|
4 | AMN |
AMN HEALTHCARE SERVICES INC
Common Stock |
S - Sale | -1.800 | 3.732 | -32,54 | 37,81 | -68.058 | 141.107 | |
| 2016-09-09 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | -1.800 | 15.643 | -10,32 | 94,62 | -170.325 | 1.480.219 | |
| 2016-06-03 |
|
4 | RGLS |
Regulus Therapeutics Inc.
Stock Option (Right to Buy) |
A - Award | 36.620 | 36.620 | |||||
| 2016-05-26 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
A - Award | 5.450 | 17.443 | 45,44 | 0,00 | 5 | 17 | |
| 2016-04-22 |
|
4 | AHS |
AMN HEALTHCARE SERVICES INC
Restricted Stock Units |
A - Award | 3.793 | 3.793 | |||||
| 2016-04-22 |
|
4 | AHS |
AMN HEALTHCARE SERVICES INC
Restricted Stock Units |
M - Exercise | -5.532 | 0 | -100,00 | ||||
| 2016-04-22 |
|
4 | AHS |
AMN HEALTHCARE SERVICES INC
Common Stock |
M - Exercise | 5.532 | 5.532 | |||||
| 2015-09-02 |
|
4 | BIOC |
BIOCEPT INC
Employee Stock Option (right to buy) |
A - Award | 50.000 | 50.000 | |||||
| 2015-08-20 | 3 | BIOC |
BIOCEPT INC
No securities are beneficially owned |
0 | ||||||||
| 2015-08-13 |
|
4 | RGLS |
Regulus Therapeutics Inc.
Common Stock |
P - Purchase | 10.000 | 10.000 | 7,64 | 76.405 | 76.405 | ||
| 2015-06-26 |
|
4 | RGLS |
Regulus Therapeutics Inc.
Stock Option (Right to Buy) |
A - Award | 17.500 | 17.500 | |||||
| 2015-06-05 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
A - Award | 4.671 | 11.993 | 63,79 | 0,00 | 5 | 12 | |
| 2015-04-24 |
|
4 | AHS |
AMN HEALTHCARE SERVICES INC
Restricted Stock Units |
A - Award | 5.532 | 5.532 | |||||
| 2014-11-19 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
A - Award | 6.866 | 7.322 | 1.505,70 | 0,00 | 7 | 7 | |
| 2014-11-19 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
A - Award | 456 | 456 | 0,00 | 0 | 0 | ||
| 2014-11-12 |
|
4 | AMBI |
AMBIT BIOSCIENCES CORP
Stock Option (Right to Buy) |
D - Sale to Issuer | -8.000 | 0 | -100,00 | 8,67 | -69.360 | ||
| 2014-11-12 |
|
4 | AMBI |
AMBIT BIOSCIENCES CORP
Stock Option (Right to Buy) |
D - Sale to Issuer | -14.000 | 0 | -100,00 | 3,91 | -54.740 | ||
| 2014-05-22 |
|
4 | "RGLS" |
Regulus Therapeutics Inc.
Stock Option (Right to Buy) |
A - Award | 17.500 | 17.500 | |||||
| 2014-05-16 |
|
4 | AMBI |
AMBIT BIOSCIENCES CORP
Stock Option (right to buy) |
A - Award | 8.000 | 8.000 | |||||
| 2014-04-25 |
|
4 | AHS |
AMN HEALTHCARE SERVICES INC
Restricted Stock Units |
A - Award | 10.490 | 10.490 | |||||
| 2014-01-27 |
|
4 | AMBI |
AMBIT BIOSCIENCES CORP
Stock Option (Right to Buy) |
A - Award | 14.000 | 14.000 | |||||
| 2013-06-10 |
|
4 | RGLS |
Regulus Therapeutics Inc.
Stock Option (Right to Buy) |
A - Award | 17.500 | 17.500 | |||||
| 2013-04-25 |
|
4 | AHS |
AMN HEALTHCARE SERVICES INC
Restricted Stock Units |
A - Award | 10.015 | 10.015 | |||||
| 2013-01-31 |
|
4 | RGLS |
Regulus Therapeutics Inc.
Stock Option (Right to Buy) |
A - Award | 30.000 | 30.000 | |||||
| 2013-01-31 | 3 | RGLS |
Regulus Therapeutics Inc.
Common Stock |
0 | ||||||||
| 2012-12-12 |
|
4 | AHS |
AMN HEALTHCARE SERVICES INC
Restricted Stock Units |
A - Award | 4.092 | 4.092 | |||||
| 2012-08-10 |
|
4 | AMLN |
AMYLIN PHARMACEUTICALS INC
Performance Shares |
J - Other | -40.000 | 0 | -100,00 | 31,00 | -1.240.000 | ||
| 2012-08-10 |
|
4 | AMLN |
AMYLIN PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
H - Other | -46.799 | 0 | -100,00 | ||||
| 2012-08-10 |
|
4 | AMLN |
AMYLIN PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
H - Other | -67.289 | 0 | -100,00 | ||||
| 2012-08-10 |
|
4 | AMLN |
AMYLIN PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
J - Other | -65.980 | 0 | -100,00 | 31,00 | -2.045.380 | ||
| 2012-08-10 |
|
4 | AMLN |
AMYLIN PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
J - Other | -34.884 | 0 | -100,00 | 31,00 | -1.081.404 | ||
| 2012-08-10 |
|
4 | AMLN |
AMYLIN PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
J - Other | -23.722 | 0 | -100,00 | 31,00 | -735.382 | ||
| 2012-08-10 |
|
4 | AMLN |
AMYLIN PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
J - Other | -44.243 | 0 | -100,00 | 31,00 | -1.371.533 | ||
| 2012-08-10 |
|
4 | AMLN |
AMYLIN PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
J - Other | -35.475 | 0 | -100,00 | 31,00 | -1.099.725 | ||
| 2012-08-10 |
|
4 | AMLN |
AMYLIN PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
J - Other | -112.207 | 0 | -100,00 | 31,00 | -3.478.417 | ||
| 2012-08-10 |
|
4 | AMLN |
AMYLIN PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
J - Other | -70.843 | 0 | -100,00 | 31,00 | -2.196.133 | ||
| 2012-08-10 |
|
4 | AMLN |
AMYLIN PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
J - Other | -56.248 | 0 | -100,00 | 31,00 | -1.743.688 | ||
| 2012-08-10 |
|
4 | AMLN |
AMYLIN PHARMACEUTICALS INC
Incentive Stock Option (right to buy) |
H - Other | -3.201 | 0 | -100,00 | ||||
| 2012-08-10 |
|
4 | AMLN |
AMYLIN PHARMACEUTICALS INC
Incentive Stock Option (right to buy) |
H - Other | -2.711 | 0 | -100,00 | ||||
| 2012-08-10 |
|
4 | AMLN |
AMYLIN PHARMACEUTICALS INC
Incentive Stock Option (right to buy) |
J - Other | -4.020 | 0 | -100,00 | 31,00 | -124.620 | ||
| 2012-08-10 |
|
4 | AMLN |
AMYLIN PHARMACEUTICALS INC
Incentive Stock Option (right to buy) |
J - Other | -5.116 | 0 | -100,00 | 31,00 | -158.596 | ||
| 2012-08-10 |
|
4 | AMLN |
AMYLIN PHARMACEUTICALS INC
Incentive Stock Option (right to buy) |
J - Other | -8.361 | 0 | -100,00 | 31,00 | -259.191 | ||
| 2012-08-10 |
|
4 | AMLN |
AMYLIN PHARMACEUTICALS INC
Incentive Stock Option (right to buy) |
J - Other | -5.757 | 0 | -100,00 | 31,00 | -178.467 | ||
| 2012-08-10 |
|
4 | AMLN |
AMYLIN PHARMACEUTICALS INC
Incentive Stock Option (right to buy) |
J - Other | -4.525 | 0 | -100,00 | 31,00 | -140.275 | ||
| 2012-08-10 |
|
4 | AMLN |
AMYLIN PHARMACEUTICALS INC
Incentive Stock Option (right to buy) |
J - Other | -7.793 | 0 | -100,00 | 31,00 | -241.583 | ||
| 2012-08-10 |
|
4 | AMLN |
AMYLIN PHARMACEUTICALS INC
Incentive Stock Option (right to buy) |
J - Other | -9.157 | 0 | -100,00 | 31,00 | -283.867 | ||
| 2012-08-10 |
|
4 | AMLN |
AMYLIN PHARMACEUTICALS INC
Incentive Stock Option (right to buy) |
J - Other | -3.752 | 0 | -100,00 | 31,00 | -116.312 | ||
| 2012-08-10 |
|
4 | AMLN |
AMYLIN PHARMACEUTICALS INC
Common Stock |
U - Other | -110 | 0 | -100,00 | 31,00 | -3.410 | ||
| 2012-08-10 |
|
4 | AMLN |
AMYLIN PHARMACEUTICALS INC
Common Stock |
U - Other | -2.889 | 0 | -100,00 | 31,00 | -89.568 | ||
| 2012-08-10 |
|
4 | AMLN |
AMYLIN PHARMACEUTICALS INC
Common Stock |
U - Other | -5.085 | 2.889 | -63,77 | 31,00 | -157.638 | 89.568 | |
| 2012-08-10 |
|
4 | AMLN |
AMYLIN PHARMACEUTICALS INC
Common Stock |
U - Other | -3.415 | 0 | -100,00 | 31,00 | -105.874 | ||
| 2012-08-10 |
|
4 | AMLN |
AMYLIN PHARMACEUTICALS INC
Common Stock |
U - Other | -453 | 3.415 | -11,71 | 31,00 | -14.040 | 105.874 | |
| 2012-08-10 |
|
4 | AMLN |
AMYLIN PHARMACEUTICALS INC
Common Stock |
J - Other | -64.702 | 0 | -100,00 | 31,00 | -2.005.762 | ||
| 2012-08-10 |
|
4 | AMLN |
AMYLIN PHARMACEUTICALS INC
Common Stock |
U - Other | -65.115 | 64.702 | -50,16 | 31,00 | -2.018.565 | 2.005.762 | |
| 2012-08-10 |
|
4 | AMLN |
AMYLIN PHARMACEUTICALS INC
Common Stock |
U - Other | -8.255 | 129.817 | -5,98 | 31,00 | -255.905 | 4.024.327 | |
| 2012-08-10 |
|
4 | AMLN |
AMYLIN PHARMACEUTICALS INC
Common Stock |
J - Other | 64.702 | 138.072 | 88,19 | 31,00 | 2.005.762 | 4.280.232 | |
| 2012-07-26 |
|
4 | AMLN |
AMYLIN PHARMACEUTICALS INC
Common Stock |
A - Award | 880 | 73.370 | 1,21 | 14,62 | 12.866 | 1.072.669 | |
| 2012-03-07 |
|
4 | AMLN |
AMYLIN PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
A - Award | 112.207 | 112.207 | |||||
| 2012-03-07 |
|
4 | AMLN |
AMYLIN PHARMACEUTICALS INC
Incentive Stock Option (right to buy) |
A - Award | 7.793 | 7.793 | |||||
| 2012-03-07 |
|
4 | AMLN |
AMYLIN PHARMACEUTICALS INC
Common Stock |
A - Award | 1.529 | 7.974 | 23,73 | ||||
| 2012-03-07 |
|
4 | AMLN |
AMYLIN PHARMACEUTICALS INC
Common Stock |
A - Award | 10.000 | 72.490 | 16,00 | ||||
| 2012-03-02 |
|
4 | AMLN |
AMYLIN PHARMACEUTICALS INC
Common Stock |
S - Sale | -1.846 | 62.490 | -2,87 | 17,11 | -31.585 | 1.069.204 | |
| 2012-02-24 |
|
4 | AMLN |
AMYLIN PHARMACEUTICALS INC
Common Stock |
S - Sale | -5.638 | 63.439 | -8,16 | 17,03 | -96.016 | 1.080.379 | |
| 2012-02-24 |
|
4 | AMLN |
AMYLIN PHARMACEUTICALS INC
Common Stock |
A - Award | 15.000 | 69.077 | 27,74 | ||||
| 2012-02-15 |
|
5 | AMLN |
AMYLIN PHARMACEUTICALS INC
Common Stock |
A - Award | -488 | 41.699 | -1,16 | ||||
| 2012-02-10 |
|
4 | AMLN |
AMYLIN PHARMACEUTICALS INC
Common Stock |
F - Taxes | -3.122 | 54.565 | -5,41 | 16,47 | -51.419 | 898.686 | |
| 2012-02-10 |
|
4 | AMLN |
AMYLIN PHARMACEUTICALS INC
Common Stock |
A - Award | 8.000 | 57.687 | 16,10 | ||||
| 2012-01-12 |
|
4 | AMLN |
AMYLIN PHARMACEUTICALS INC
Common Stock |
A - Award | 7.500 | 49.687 | 17,78 | ||||
| 2008-02-05 |
|
4 | AMLN |
AMYLIN PHARMACEUTICALS INC
Common Stock |
A - Award | 182 | 23.753 | 0,77 | 37,00 | 6.734 | 878.861 |
